{
  "ticker": "VRTX",
  "company_name": "Vertex Pharmaceuticals",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01153542",
      "title": "Study of VX-770 on Desipramine",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "In Development for Cystic Fibrosis",
      "start_date": "2010-06",
      "completion_date": "2010-08",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT04043806",
      "title": "A Study Evaluating the Long-term Safety of VX-445 Combination Therapy",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Cystic Fibrosis",
      "start_date": "2019-08-09",
      "completion_date": "2022-12-14",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT05477563",
      "title": "Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent \u03b2-Thalassemia and Severe Sickle Cell Disease",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Beta-Thalassemia, Thalassemia, Hematologic Diseases, Genetic Diseases, Inborn, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Anemia",
      "start_date": "2022-08-02",
      "completion_date": "2027-06-09",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT01705145",
      "title": "Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Cystic Fibrosis",
      "start_date": "2013-01",
      "completion_date": "2014-03",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT05418712",
      "title": "A Microneurography (MNG) Study of VX-150 in Healthy Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Pain",
      "start_date": "2022-06-16",
      "completion_date": "2022-09-23",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT07161037",
      "title": "Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Autosomal Dominant Polycystic Kidney Disease (ADPKD)",
      "start_date": "2025-11-19",
      "completion_date": "2027-12-31",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT01275599",
      "title": "Drug-Drug Interaction Study Between Telaprevir and Buprenorphine",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Hepatitis C, Opioid-Related Disorders",
      "start_date": "2011-01",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT03163511",
      "title": "A Safety, Tolerability, and Efficacy Study of VC-02\u2122 Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Type 1 Diabetes Mellitus With Hypoglycemia",
      "start_date": "2017-07-06",
      "completion_date": "2023-10-19",
      "enrollment": 0,
      "sponsor": "ViaCyte"
    },
    {
      "nct_id": "NCT01768663",
      "title": "A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Cystic Fibrosis",
      "start_date": "2013-01",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    },
    {
      "nct_id": "NCT00273936",
      "title": "Trial of AVN-944 in Patients With Advanced Hematologic Malignancies",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Acute Leukemia, Chronic Leukemia, Multiple Myeloma, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Waldenstrom's Macroglobulinemia",
      "start_date": "2006-01",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Vertex Pharmaceuticals Incorporated"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1": 12,
      "PHASE3": 17,
      "PHASE2": 10,
      "PHASE1, PHASE2": 2,
      "NA": 2,
      "PHASE4": 1,
      "": 5,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 35,
      "RECRUITING": 6,
      "TERMINATED": 3,
      "ENROLLING_BY_INVITATION": 2,
      "APPROVED_FOR_MARKETING": 1,
      "ACTIVE_NOT_RECRUITING": 1,
      "WITHDRAWN": 1,
      "UNKNOWN": 1
    },
    "active_trials": 9,
    "completed_trials": 35,
    "conditions": [
      "Acute Leukemia, Chronic Leukemia, Multiple Myeloma, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Waldenstrom's Macroglobulinemia",
      "Acute Pain",
      "Alpha-1 Antitrypsin Deficiency",
      "Autosomal Dominant Polycystic Kidney Disease (ADPKD)",
      "Beta-Thalassemia, Thalassemia, Hematologic Diseases, Genetic Diseases, Inborn, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Anemia",
      "Chronic Hepatitis C",
      "Chronic Hepatitis C, Hemophilia",
      "Chronic Obstructive Pulmonary Disease",
      "Cystic Fibrosis",
      "Cystic Fibrosis, Advanced Lung Disease",
      "Cystic Fibrosis, Cystic Fibrosis-related Diabetes",
      "Cystic Fibrosis, Homozygous for the F508del CFTR Mutation",
      "Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia",
      "Diabetic Peripheral Neuropathic Pain",
      "Hepatitis C",
      "Hepatitis C, Opioid-Related Disorders",
      "In Development for Cystic Fibrosis",
      "Myotonic Dystrophy Type 1 (DM1)",
      "Pain",
      "Proteinuric Kidney Disease",
      "Small Fiber Neuropathy",
      "Type 1 Diabetes",
      "Type 1 Diabetes Mellitus With Hypoglycemia"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:03:12.190677",
    "search_query": "Vertex Pharmaceuticals",
    "url": "https://clinicaltrials.gov/search?term=Vertex+Pharmaceuticals"
  }
}